R&D Systems™ Human CXCL1/GRO alpha/KC/CINC-1 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 275GR010/CF
DescriptionThe Recombinant Human CXCL1/GRO alpha Protein is derived from E. coli. The Recombinant Human CXCL1/GRO alpha Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|E. coli-derived human CXCL1/GRO alpha/KC/CINC-1 protein Ala35-Asn107|
|CINC1, CINC-1, FSP, GRO alpha, GRO1, GROa, KC, MGSA, MGSA-a, MGSA-alpha, NAP-3, SCYB1|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok